Eric M. Mucker

United States Army Medical Research Institute of Infectious Diseases — United States

Immunology and Microbiology · Life Sciences

27h-index2.6kcitations51works12.32yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Poxvirus research and outbreaks(31), Herpesvirus Infections and Treatments(24), Bacillus and Francisella bacterial research(22), SARS-CoV-2 and COVID-19 Research(10), Viral Infections and Outbreaks Research(8)

Publications51 total

219. Safety and Immunogenicity of BNT166a, an Investigational Quadrivalent mRNA Mpox Vaccine
Open Forum Infectious Diseases·2026Open Access
Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxviruses and African Swine Fever Virus
ACS Infectious Diseases·2025· 2 cited
Stability and characterization of infectious monkeypox virus extracellular virions in vitro and vivo; implications for transmission, pathogenesis and treatment
2025Open Access
<i>In vitro</i> and <i>in vivo</i> Antiviral Activity of the Acyclic Nucleoside Phosphonate Prodrug LAVR-289 against Poxvirus and African Swine Fever Virus Replication
2025
Mpox mRNA-1769 vaccine inhibits orthopoxvirus replication at intranasal, intrarectal, and cutaneous sites of inoculation
npj Vaccines·2024· 9 citedOpen Access
Mpox mRNA-1769 Vaccine Inhibits Orthopoxvirus Replication at Intranasal, Intrarectal, and Cutaneous Sites of Inoculation
2024· 1 citedOpen Access
Comparison of protection against mpox following mRNA or modified vaccinia Ankara vaccination in nonhuman primates
Cell·2024· 91 citedOpen Access
Orally available nucleoside analog UMM-766 provides protection in a murine model of orthopox disease
Microbiology Spectrum·2024· 7 citedOpen Access
Smallpox lesion characterization in placebo-treated and tecovirimat-treated macaques using traditional and novel methods
PLoS Pathogens·2024· 1 citedOpen Access
Development of a specific MPXV antigen detection immunodiagnostic assay
Frontiers in Microbiology·2023· 19 citedOpen Access
Evaluation of a panel of therapeutic antibody clinical candidates for efficacy against SARS-CoV-2 in Syrian hamsters
Antiviral Research·2023· 5 citedOpen Access
Retrospective detection of monkeypox virus in the testes of nonhuman primate survivors
Nature Microbiology·2022· 37 citedOpen Access
Preclinical characterization of amubarvimab and romlusevimab, a pair of non-competing neutralizing monoclonal antibody cocktail, against SARS-CoV-2
Frontiers in Immunology·2022· 19 citedOpen Access
Evaluation of Virulence in Cynomolgus Macaques Using a Virus Preparation Enriched for the Extracellular Form of Monkeypox Virus
Viruses·2022· 14 citedOpen Access
Effect of Monkeypox Virus Preparation on the Lethality of the Intravenous Cynomolgus Macaque Model
Viruses·2022· 16 citedOpen Access
SARS-CoV-2 Doggybone DNA Vaccine Produces Cross-Variant Neutralizing Antibodies and Is Protective in a COVID-19 Animal Model
Vaccines·2022· 9 citedOpen Access
Lipid nanoparticle delivery of unmodified mRNAs encoding multiple monoclonal antibodies targeting poxviruses in rabbits
Molecular Therapy — Nucleic Acids·2022· 34 citedOpen Access
Hamsters Expressing Human Angiotensin-Converting Enzyme 2 Develop Severe Disease following Exposure to SARS-CoV-2
mBio·2022· 28 citedOpen Access
Rapid discovery of diverse neutralizing SARS-CoV-2 antibodies from large-scale synthetic phage libraries
mAbs·2021· 30 citedOpen Access
Human convalescent plasma protects K18-hACE2 mice against severe respiratory disease
Journal of General Virology·2021· 11 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Jay W. Hooper(18), John W. Huggins(13), Joseph W. Golden(11), Joshua D. Shamblin(10), Arthur J. Goff(10), Xiankun Zeng(8), Lisa E. Hensley(8), Jennifer Chapman(7), Aura R. Garrison(6), Nancy Twenhafel(6), David Miller(5), Curtis R. Cline(5), Rebecca L. Brocato(5), Josh Shamblin(5), Steven A. Kwilas(5), Janice A. Williams(5), Patricia L. Earl(4), Jeffrey L. Americo(4), David A. Kulesh(4), Susan H. Zwiers(4)